Mitobe, M., Kawamoto, K., Suzuki, T., Kiryu, M., Tamura, S., Nanba, A., . . . Takizawa, J. (2018). Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. Intern Med.
Citação norma ChicagoMitobe, Masaki, et al. "Gemcitabine, Dexamethasone, and Cisplatin Regimen As an Effective Salvage Therapy for High-grade B-cell Lymphoma With MYC and BCL2 And/or BCL6 Rearrangements." Intern Med 2018.
MLA citiranjeMitobe, Masaki, et al. "Gemcitabine, Dexamethasone, and Cisplatin Regimen As an Effective Salvage Therapy for High-grade B-cell Lymphoma With MYC and BCL2 And/or BCL6 Rearrangements." Intern Med 2018.
Opozorilo: Ti citati niso vedno 100% točni.